OTCPK:TLPPF (Australia)
Â
Ordinary Shares
$
16.70
+0.7 (+4.38%)
11:09 PM EST
New Key Statistics Module, Z-Score and F-Score
OTCPK:TLPPF Key Ratios
| Market Cap $ M | 5,527.19 |
| Enterprise Value $ M | 5,527.19 |
| P/E(ttm) | 178.46 |
| PE Ratio without NRI | 178.46 |
| Forward PE Ratio | 81.46 |
| Price/Book | 21.99 |
| Price/Sales | 13.80 |
| Price/Free Cash Flow | 422.06 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 424.00 |
| EPS (TTM) $ | 0.10 |
| Beneish M-Score | -0.61 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 135.43 |
| EV-to-EBITDA | 121.98 |
| PEG | -- |
| Shares Outstanding M | 334.72 |
| Net Margin (%) | 7.72 |
| Operating Margin % | 12.49 |
| Pre-tax Margin (%) | 7.86 |
| Quick Ratio | 0.87 |
| Current Ratio | 0.99 |
| ROA % (ttm) | 10.14 |
| ROE % (ttm) | 23.46 |
| ROIC % (ttm) | 21.54 |
| Dividend Yield % | -- |
| Altman Z-Score | 22.07 |
TLPPF Number of Guru Trades
TLPPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TLPPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TLPPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Telix Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:TLPPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers